169 related articles for article (PubMed ID: 25869956)
1. Psoralen derivatives as inhibitors of NF-κB interaction: the critical role of the furan ring.
Marzaro G; Lampronti I; Borgatti M; Manzini P; Gambari R; Chilin A
Mol Divers; 2015 Aug; 19(3):551-61. PubMed ID: 25869956
[TBL] [Abstract][Full Text] [Related]
2. Biological evaluation, chelation, and molecular modeling studies of novel metal-chelating inhibitors of NF-kappaB-DNA binding: structure activity relationships.
Sharma RK; Chopra S; Sharma SD; Pande V; Ramos MJ; Meguro K; Inoue J; Otsuka M
J Med Chem; 2006 Jun; 49(12):3595-601. PubMed ID: 16759101
[TBL] [Abstract][Full Text] [Related]
3. Psoralen derivatives as inhibitors of NF-κB/DNA interaction: synthesis, molecular modeling, 3D-QSAR, and biological evaluation.
Marzaro G; Guiotto A; Borgatti M; Finotti A; Gambari R; Breveglieri G; Chilin A
J Med Chem; 2013 Mar; 56(5):1830-42. PubMed ID: 23414143
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives.
Meleddu R; Deplano S; Maccioni E; Ortuso F; Cottiglia F; Secci D; Onali A; Sanna E; Angeli A; Angius R; Alcaro S; Supuran CT; Distinto S
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):685-692. PubMed ID: 33602041
[TBL] [Abstract][Full Text] [Related]
5. Psoralen Derivatives: Recent Advances of Synthetic Strategy and Pharmacological Properties.
Jamalis J; Yusof FSM; Chander S; Wahab RA; P Bhagwat D; Sankaranarayanan M; Almalki F; Hadda TB
Antiinflamm Antiallergy Agents Med Chem; 2020; 19(3):222-239. PubMed ID: 31241020
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationship study of triazine-based inhibitors of the DNA binding of NF-κB.
Fujii S; Kobayashi T; Nakatsu A; Miyazawa H; Kagechika H
Chem Pharm Bull (Tokyo); 2014; 62(7):700-8. PubMed ID: 24990506
[TBL] [Abstract][Full Text] [Related]
7. Single-nucleotide mutation matrix: a new model for predicting the NF-κB DNA binding sites.
Du W; Gao J; Wang T; Wang J
PLoS One; 2014; 9(7):e101490. PubMed ID: 24992458
[TBL] [Abstract][Full Text] [Related]
8. Electrophoretic mobility shift assay analysis of NF-κB DNA binding.
Ramaswami S; Hayden MS
Methods Mol Biol; 2015; 1280():3-13. PubMed ID: 25736740
[TBL] [Abstract][Full Text] [Related]
9. Evans Blue is an inhibitor of nuclear factor-kappa B (NF-kappaB)-DNA binding.
Sharma RK; Otsuka M; Pande V; Inoue J; João Ramos M
Bioorg Med Chem Lett; 2004 Dec; 14(24):6123-7. PubMed ID: 15546742
[TBL] [Abstract][Full Text] [Related]
10. The x-ray crystal structure of the NF-kappa B p50.p65 heterodimer bound to the interferon beta -kappa B site.
Berkowitz B; Huang DB; Chen-Park FE; Sigler PB; Ghosh G
J Biol Chem; 2002 Jul; 277(27):24694-700. PubMed ID: 11970948
[TBL] [Abstract][Full Text] [Related]
11. Minimal NF-κB activity in neurons.
Listwak SJ; Rathore P; Herkenham M
Neuroscience; 2013 Oct; 250():282-299. PubMed ID: 23872390
[TBL] [Abstract][Full Text] [Related]
12. Activation of early signaling transcription factor, NF-kappaB following low-level manganese exposure.
Ramesh GT; Ghosh D; Gunasekar PG
Toxicol Lett; 2002 Dec; 136(2):151-8. PubMed ID: 12425965
[TBL] [Abstract][Full Text] [Related]
13. Cross-linking of DNA-binding proteins to DNA with psoralen and psoralen furan-side monoadducts. Comparison of action spectra with DNA-DNA cross-linking.
Sastry SS; Ross BM; P'arraga A
J Biol Chem; 1997 Feb; 272(6):3715-23. PubMed ID: 9013628
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of a free kappaB DNA: insights into DNA recognition by transcription factor NF-kappaB.
Huang DB; Phelps CB; Fusco AJ; Ghosh G
J Mol Biol; 2005 Feb; 346(1):147-60. PubMed ID: 15663934
[TBL] [Abstract][Full Text] [Related]
15. Detection of a ternary complex of NF-kappaB and IkappaBalpha with DNA provides insights into how IkappaBalpha removes NF-kappaB from transcription sites.
Sue SC; Alverdi V; Komives EA; Dyson HJ
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1367-72. PubMed ID: 21220295
[TBL] [Abstract][Full Text] [Related]
16. Molecular mimicry of the NF-kappaB DNA target site by a selected RNA aptamer.
Ghosh G; Huang DB; Huxford T
Curr Opin Struct Biol; 2004 Feb; 14(1):21-7. PubMed ID: 15102445
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of 2,3-dihydro- and 5-chloro-2,3-dihydro-naphtho-[1,2-b]furan-2-carboxylic acid N-(substitutedphenyl)amide analogs and their biological activities as inhibitors of NF-κB activity and anticancer agents.
Choi M; Jo H; Kim D; Yun J; Kang JS; Kim Y; Jung JK; Hong JT; Cho J; Kwak JH; Lee H
Arch Pharm Res; 2016 May; 39(5):618-30. PubMed ID: 27021311
[TBL] [Abstract][Full Text] [Related]
18. [Psoralen and isopsoralen improve lipid metabolism disorder via inhibition of NF-κB activation in LO2 cells].
Zhou LS; Yan SQ; Xiong XL; Huang J; Qin H; Zhang LL; Zhang LL; Tang JQ
Zhongguo Zhong Yao Za Zhi; 2019 May; 44(10):2118-2123. PubMed ID: 31355570
[TBL] [Abstract][Full Text] [Related]
19. Theoretical studies on pyrimidine substituent derivatives as dual inhibitors of AP-1 and NF-kappaB.
Qian L; Liao SY; Huang ZL; Shen Y; Zheng KC
J Mol Model; 2010 Jun; 16(6):1139-50. PubMed ID: 19943176
[TBL] [Abstract][Full Text] [Related]
20. Structure and mechanism in NF-kappa B/I kappa B signaling.
Huxford T; Malek S; Ghosh G
Cold Spring Harb Symp Quant Biol; 1999; 64():533-40. PubMed ID: 11232330
[No Abstract] [Full Text] [Related]
[Next] [New Search]
